Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
Detect a dose-response of BGG492 as measured by change in seizure frequency from the 4-week baseline period (week -4 to .1) to the 4-week double-blind maintenance period (weeks 7 to 10).
Critère d'inclusion
- refractory partial-onset seizures